Avadel Pharmaceuticals (AVDL) Interest & Investment Income (2016 - 2020)
Historic Interest & Investment Income for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q4 2020 value amounting to $74000.0.
- Avadel Pharmaceuticals' Interest & Investment Income rose 10500.34% to $74000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$1.9 million, marking a year-over-year decrease of 28082.32%. This contributed to the annual value of -$832000.0 for FY2020, which is 17782.97% down from last year.
- Per Avadel Pharmaceuticals' latest filing, its Interest & Investment Income stood at $74000.0 for Q4 2020, which was up 10500.34% from $213000.0 recorded in Q3 2020.
- In the past 5 years, Avadel Pharmaceuticals' Interest & Investment Income registered a high of $977000.0 during Q3 2017, and its lowest value of -$1.5 million during Q4 2019.
- Over the past 5 years, Avadel Pharmaceuticals' median Interest & Investment Income value was $390000.0 (recorded in 2016), while the average stood at $292210.5.
- The largest annual percentage gain for Avadel Pharmaceuticals' Interest & Investment Income in the last 5 years was 141296.3% (2019), contrasted with its biggest fall of 27633.59% (2019).
- Avadel Pharmaceuticals' Interest & Investment Income (Quarter) stood at $555000.0 in 2016, then tumbled by 48.11% to $288000.0 in 2017, then crashed by 236.46% to -$393000.0 in 2018, then plummeted by 276.34% to -$1.5 million in 2019, then surged by 105.0% to $74000.0 in 2020.
- Its Interest & Investment Income was $74000.0 in Q4 2020, compared to $213000.0 in Q3 2020 and -$741000.0 in Q2 2020.